Pricing Wars and Policy Shifts: The Economics of GLP-1 Access

ha aggiunto una foto Health

2026-03-05 11:27:01 -

Despite the overwhelming clinical success of incretin therapies, the GLP-1 Drug Market faces intense scrutiny regarding drug pricing, affordability, and equitable patient access. Historically, the list price for a month's supply of branded injectable GLP-1s for weight loss in the United States hovered between $1,000 and $1,350. This exorbitant cost, combined with widespread reluctance among...

0 Commenti 0 condivisioni 412 Views 0 Anteprima